| Dr Simon Chin Oh, MD | |
|
1444 S. Potomac St, #280, Aurora, CO 80012-4509 | |
| (303) 481-0030 | |
| (720) 748-0503 |
| Full Name | Dr Simon Chin Oh |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 20 Years |
| Location | 1444 S. Potomac St, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649236191 | NPI | - | NPPES |
| 87923271 | Medicaid | CO | |
| 35297800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 49292 (Colorado) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 49036 (Wisconsin) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Colorado Neurology Center Pllc | 9830413335 | 2 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.
A new modeling study illustrates how accounting for factors such as age and social activity influences the predicted herd immunity threshold for COVID-19, or the level of population immunity needed to stop the disease's transmission.
Blue Cross Blue Shield of Massachusetts exceeded federal standards by $396 million and state standards by $242 million in the amount it spent on medical benefits on behalf of its members in 2012.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
› Verified 9 days ago
| Entity Name | Colorado Neurology Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851796627 PECOS PAC ID: 9830413335 Enrollment ID: O20150109000993 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.
A new modeling study illustrates how accounting for factors such as age and social activity influences the predicted herd immunity threshold for COVID-19, or the level of population immunity needed to stop the disease's transmission.
Blue Cross Blue Shield of Massachusetts exceeded federal standards by $396 million and state standards by $242 million in the amount it spent on medical benefits on behalf of its members in 2012.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Simon Chin Oh, MD 4900 S Monaco St, #210, Denver, CO 80237-3486 Ph: (303) 481-0030 | Dr Simon Chin Oh, MD 1444 S. Potomac St, #280, Aurora, CO 80012-4509 Ph: (303) 481-0030 |
News Archive
The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.
A new modeling study illustrates how accounting for factors such as age and social activity influences the predicted herd immunity threshold for COVID-19, or the level of population immunity needed to stop the disease's transmission.
Blue Cross Blue Shield of Massachusetts exceeded federal standards by $396 million and state standards by $242 million in the amount it spent on medical benefits on behalf of its members in 2012.
Novartis Pharmaceuticals Corporation announced today that results from a Phase II study show Afinitor® (everolimus) tablets is the first medication in a clinical trial to decrease the size of subependymal giant cell astrocytomas (SEGAs), benign brain tumors associated with tuberous sclerosis (TS). In this study of 28 patients presented today at the 46th American Society of Clinical Oncology (ASCO) annual meeting in Chicago, 75% of patients experienced a reduction of 30% or greater in the size of their brain tumors from baseline to six months (p<0.001).
› Verified 9 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |